CD8A and neoplasm: The anti-tumor effect of CpG is mainly reflected in its ability to promote the activation and expansion of CD8+ T cells while reducing the number of regulatory T cells (Tregs) (Mangsbo et al. 2010; Standley et al. 2007; Wang et al. 2016).